Corvus Pharmaceuticals (CRVS) P/E (2016 - 2026)
Corvus Pharmaceuticals (CRVS) P/E from Mar 31, 2016 to Jul 21, 2026. The TTM Corvus Pharmaceuticals (CRVS) P/E is -25.34. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Corvus Pharmaceuticals (CRVS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -25.34 | -38.96% |
| 2025 | -41.51 | +680.00% |
| 2024 | -5.32 | +92.06% |
| 2023 | -2.77 | +185.19% |
| 2022 | -0.97 | -59.41% |
| 2021 | -2.39 | -84.79% |
| 2020 | -15.73 | +365.13% |
| 2019 | -3.38 | +47.93% |
| 2018 | -2.29 | -42.20% |
| 2017 | -3.96 | -66.34% |
| 2016 | -11.75 | N/A |
Comparison Corvus Pharmaceuticals (CRVS) P/E with competitors
Corvus Pharmaceuticals (CRVS) P/E is -25.34.